RPR107393 - A SQUALENE SYNTHASE INHIBITOR AND A POTENT CHOLESTEROL-LOWERING AGENT

被引：0

作者：

AMIN, D ^{[1
]}

NEEDLE, S ^{[1
]}

RUTLEDGE, R ^{[1
]}

GALCZENSKI, H ^{[1
]}

BUSH, R ^{[1
]}

HELE, D ^{[1
]}

MAGUIRE, M ^{[1
]}

NEUENSCHWANDER, K ^{[1
]}

SPADA, A ^{[1
]}

BILDER, G ^{[1
]}

ROACH, A ^{[1
]}

PERRONE, M ^{[1
]}

机构：

[1] RHONE POULENC RORER,COLLEGEVILLE,PA 19426

来源：

FASEB JOURNAL | 1995年 / 9卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：A766 / A766

页数：1

共 50 条

[31] DEXTRO-THYROXINE AS A CHOLESTEROL-LOWERING AGENT IN PATIENTS WITH ANGINA PECTORIS
ROBINSON, RW
LEBEAU, RJ
CIRCULATION, 1963, 28 (04) : 531 - &
[32] Bacterial production of the fungus-derived cholesterol-lowering agent mevinolin
Bose, Utpal
Hodson, Mark P.
Shaw, P. Nicholas
Fuerst, John A.
Hewavitharana, Amitha K.
BIOMEDICAL CHROMATOGRAPHY, 2014, 28 (09) : 1163 - 1166
[33] Ezetimibe: A novel cholesterol-lowering agent that highlights novel physiologic pathways
Patel S.B.
Current Cardiology Reports, 2004, 6 (6) : 439 - 442
[34] A unique cholesterol-lowering agent that no one had ever had before
Nakamura, K
ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (03) : 19 - 20
[35] Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agent
Davidson, MH
Dicklin, MR
Maki, KC
Kleinpell, RM
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (11) : 2663 - 2671
[36] The effect of HPMC - a cholesterol-lowering agent - on oral drug absorption in dogs
Reppas, C
Eleftheriou, G
Macheras, P
Symillides, M
Greenwood, D
Dressman, JB
BIOPHARMACEUTICS & DRUG DISPOSITION, 1998, 19 (08) : 523 - 530
[37] RG-12561 (DALVASTATIN) - A NOVEL SYNTHETIC INHIBITOR OF HMG-COA REDUCTASE AND CHOLESTEROL-LOWERING AGENT
AMIN, D
GUSTAFSON, SK
WEINACHT, JM
CORNELL, SA
NEUENSCHWANDER, K
KOSMIDER, B
SCOTESE, AC
REGAN, JR
PERRONE, MH
PHARMACOLOGY, 1993, 46 (01) : 13 - 22
[38] FERMENTABLE CARBOHYDRATES EXERT A MORE POTENT CHOLESTEROL-LOWERING EFFECT THAN CHOLESTYRAMINE
FAVIER, ML
MOUNDRAS, C
DEMIGNE, C
REMESY, C
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1995, 1258 (02): : 115 - 121
[39] Perspectives in cholesterol-lowering therapy - The role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption
Bruckert, E
Giral, P
Tellier, P
CIRCULATION, 2003, 107 (25) : 3124 - 3128
[40] Inclisiran: present and future perspectives of a new effective LDL cholesterol-lowering agent
Giordano, Salvatore
Polimeni, Alberto
Esposito, Giovanni
Indolfi, Ciro
Spaccarotella, Carmen
CURRENT OPINION IN LIPIDOLOGY, 2023, 34 (04) : 133 - 140

← 1 2 3 4 5 →